Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by JamesJackon Dec 06, 2017 9:31am

138 Views

Post# 27099614

RE:Taimed to speak at Citi Global Healthcare Conference

SPCEO1 wrote: The conference is going to occur tomorrow and Wednesday. It is another indication of the maturation of Taimed/Thera situation in the financial markets and it has a long way to go. But it is nice to see it start for both companies (Piper last week for TH).

It will be interesting to see how Taimed frames things in their presentation - hopefully there will be a new presentation booklet on their website.

Is there any information about the presentation by Taimed?

Bullboard Posts

New Pacific Metals delivers robust Silver Sand pre-feasibility study